Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura MacConaill

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Endocrinology|May 10, 2017
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary TumorsWenya Linda Bi, Noah F Greenwald, Shakti H Ramkissoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaJennifer R Brown, Megan Hanna, Bethany Tesar, et al.
Genome Medicine|July 28, 2016
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicineAndrea Garofalo, Lynette Sholl, Brendan Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2016
Landscape of Genomic Alterations in Pituitary AdenomasWenya Linda Bi, Peleg Horowitz, Noah F Greenwald, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Nature Communications|December 14, 2023
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer Research|June 17, 2010
PIK3CA mutations in in situ and invasive breast carcinomasAlexander Miron, Maria Varadi, Daniel Carrasco, et al.
Endocrinology|May 10, 2017
Clinical Identification of Oncogenic Drivers and Copy-Number Alterations in Pituitary TumorsWenya Linda Bi, Noah F Greenwald, Shakti H Ramkissoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2012
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemiaJennifer R Brown, Megan Hanna, Bethany Tesar, et al.
Genome Medicine|July 28, 2016
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicineAndrea Garofalo, Lynette Sholl, Brendan Reardon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2016
Landscape of Genomic Alterations in Pituitary AdenomasWenya Linda Bi, Peleg Horowitz, Noah F Greenwald, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2014
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driverCatherine Emmanuel, Yoke-Eng Chiew, Joshy George, et al.
Nature Communications|December 14, 2023
Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Pageof 4